Holdings
Glazer Capital, LLC
As of Jun 30, 2026, Glazer Capital, LLC reported 262 positions worth US$3.38B. Largest: Nuvalent, Inc., Apogee Therapeutics, Inc. and Topbuild Corp. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Nuvalent, Inc. | 1.77M | US$219M | new | Jun 30, 2026 |
| Apogee Therapeutics, Inc. | 1.64M | US$218M | new | Jun 30, 2026 |
| Topbuild Corp. | 492K | US$210M | new | Jun 30, 2026 |
| Select Medical Holdings Corporation | 10.7M | US$177M | +6.66M | Jun 30, 2026 |
| Catalyst Pharmaceuticals, Inc. | 3.6M | US$113M | new | Jun 30, 2026 |
| Hudbay Minerals Inc | 3.55M | US$83.8M | new | Jun 30, 2026 |
| Digitalbridge Group, Inc. | 4.93M | US$77.7M | −4.37M | Jun 30, 2026 |
| Chart Industries, Inc. | 358K | US$74.8M | +206K | Jun 30, 2026 |
| Caesars Entertainment, Inc. | 2.41M | US$72.8M | new | Jun 30, 2026 |
| Esperion Therapeutics, Inc. | 22.4M | US$70.8M | new | Jun 30, 2026 |